Clinical Conversations (CE): GLP Practice Insights: GLP-1 Receptor Agonists and Bone Mineral Density (CE)
This activity explores emerging evidence on the relationship between GLP-1 receptor agonists therapy and bone mineral density. As the use of these agents expands across chronic disease states, pharmacists must understand their potential impact on bone health to support comprehensive patient care and risk mitigation.
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.